Identification of high-risk patients with a seven- biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma

Meyer, Stefanie; Buser, Lorenz; Haferkamp, Sebastian; Berneburg, Mark; Maisch, Tim; Klinkhammer-Schalke, Monika; Pauer, Armin; Vogt, Thomas; Garbe, Claus

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2023-08-29T08:56:39Z
dc.date.available	2023-08-29T08:56:39Z
dc.date.issued	2023
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/145086
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2023.01.002	de_DE
dc.subject.ddc	610	de_DE
dc.title	Identification of high-risk patients with a seven- biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_01226
utue.publikation.seiten	77-86	de_DE
utue.personen.roh	Meyer, Stefanie
utue.personen.roh	Buser, Lorenz
utue.personen.roh	Haferkamp, Sebastian
utue.personen.roh	Berneburg, Mark
utue.personen.roh	Maisch, Tim
utue.personen.roh	Klinkhammer-Schalke, Monika
utue.personen.roh	Pauer, Armin
utue.personen.roh	Vogt, Thomas
utue.personen.roh	Garbe, Claus
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	182	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE